Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA Capital. In 2002 he broke even when the S&P 500 index lost 22%. By the end of 2003, the initial $4 Million investment became $13 Million. Boston-based RA Capital invests in companies with promising drugs and technologies.
Hedge Fund - RA Capital Management
Get Email AlertsPeter Kolchinsky Bio, Returns, AUM, Net Worth

Fund Profile
Filing Period:
Fund Name: | RA Capital Management |
Manager | Peter Kolchinsky |
Portfolio Value | $7,153,595,000 |
Change This QTR | +1.31% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
---|---|---|---|---|---|---|
1. | ASND | 5,865,338 | $978,221 | -1% | 13.67% | |
2. | TGTX | 8,685,471 | $451,818 | -2% | 6.31% | |
3. | NVAX | 3,788,564 | $422,463 | +217% | 5.9% | |
4. | NKTX | 5,605,129 | $344,547 | 4.81% | ||
5. | FMTX | 9,011,651 | $314,507 | 4.39% |
Latest 13D & 13G Filings
Company | Symbol | Filed By | Filing Date | Filing |
---|---|---|---|---|
2021-03-02 | ||||
2021-02-19 | ||||
2021-02-16 | ||||
2021-02-16 |
News, Interviews and Investor Letters